Krystal Biotech (KRYS) Other Non-Current Assets (2018 - 2026)
Krystal Biotech (KRYS) reported Other Non-Current Assets of $300000.0 for Q1 2026, up 37.61% on a YoY basis from $218000.0 in Q1 2025, and up 4.53% sequentially from $287000.0 in Q4 2025.
Krystal Biotech (KRYS) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 9 years of Other Non-Current Assets data on file, last reported at $300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 37.61% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $300000.0 (up 37.61% YoY), and the FY2025 full-year result was $287000.0, up 24.24% from the prior year.
- Other Non-Current Assets advanced to $300000.0 in Q1 2026, from $287000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $402000.0 in Q1 2023 to a low of $126000.0 in Q2 2024.
- A 5-year average of $245352.9 and a median of $231000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 337.84% in 2022 and plunged 55.79% in 2024, its largest moves.
- Tracing KRYS's Other Non-Current Assets over 5 years: stood at $324000.0 in 2022, then fell by 18.83% to $263000.0 in 2023, then slipped by 12.17% to $231000.0 in 2024, then rose by 24.24% to $287000.0 in 2025, then advanced by 4.53% to $300000.0 in 2026.
- Business Quant data shows KRYS's Other Non-Current Assets at $300000.0 in Q1 2026, $287000.0 in Q4 2025, and $333000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 287,000.00 |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 218,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 196,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Sep 30, 2023 | 285,000.00 |
| Jun 30, 2023 | 285,000.00 |
| Mar 31, 2023 | 402,000.00 |
| Dec 31, 2022 | 324,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Jun 30, 2022 | 159,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 110,000.00 |